BBLG Annual CFF
$5.04 M
+$614.30 K+13.87%
31 December 2023
Summary:
As of January 23, 2025, BBLG annual cash flow from financing activities is $5.04 million, with the most recent change of +$614.30 thousand (+13.87%) on December 31, 2023. During the last 3 years, it has risen by +$4.64 million (+1152.28%). BBLG annual CFF is now -36.18% below its all-time high of $7.90 million, reached on December 31, 2021.BBLG Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BBLG Quarterly CFF
$1.81 M
+$1.81 M+602066.67%
30 September 2024
Summary:
As of January 23, 2025, BBLG quarterly cash flow from financing activities is $1.81 million, with the most recent change of +$1.81 million (+602066.67%) on September 30, 2024. Over the past year, it has increased by +$1.81 million (+602066.67%). BBLG quarterly CFF is now -73.66% below its all-time high of $6.86 million, reached on December 31, 2021.BBLG Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BBLG TTM CFF
$3.90 M
+$1.81 M+86.16%
30 September 2024
Summary:
As of January 23, 2025, BBLG TTM cash flow from financing activities is $3.90 million, with the most recent change of +$1.81 million (+86.16%) on September 30, 2024. Over the past year, it has increased by +$1.81 million (+86.16%). BBLG TTM CFF is now -56.05% below its all-time high of $8.88 million, reached on June 30, 2023.BBLG TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BBLG Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +13.9% | +10000.0% | +86.2% |
| 3 y3 years | +1152.3% | -59.4% | -56.0% |
| 5 y5 years | +15.4% | -59.4% | -56.0% |
BBLG Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -36.2% | +13.9% | -73.7% | -56.0% | +86.2% | |
| 5 y | 5-year | -36.2% | +1152.3% | -73.7% | -56.0% | +876.8% | |
| alltime | all time | -36.2% | +1152.3% | -73.7% | -56.0% |
Bone Biologics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.81 M(>+9900.0%) | $3.90 M(+86.2%) |
| June 2024 | - | $300.00(-100.0%) | $2.10 M(-68.0%) |
| Mar 2024 | - | $1.50 M(+154.1%) | $6.55 M(+29.8%) |
| Dec 2023 | $5.04 M(+13.9%) | $592.00 K(>+9900.0%) | $5.04 M(-43.2%) |
| Sept 2023 | - | $0.00(-100.0%) | $8.88 M(0.0%) |
| June 2023 | - | $4.45 M(>+9900.0%) | $8.88 M(+100.5%) |
| Mar 2023 | - | $0.00(-100.0%) | $4.43 M(0.0%) |
| Dec 2022 | $4.43 M(-44.0%) | $4.43 M(>+9900.0%) | $4.43 M(-35.4%) |
| Sept 2022 | - | $0.00(0.0%) | $6.86 M(-3.9%) |
| June 2022 | - | $0.00(-100.0%) | $7.14 M(-9.7%) |
| Dec 2021 | $7.90 M(+1862.3%) | $6.86 M(+2378.8%) | $7.90 M(+576.5%) |
| Sept 2021 | - | $276.70 K(-51.4%) | $1.17 M(+20.9%) |
| June 2021 | - | $569.30 K(+185.9%) | $966.30 K(+104.0%) |
| Mar 2021 | - | $199.10 K(+61.6%) | $473.70 K(+17.6%) |
| Dec 2020 | $402.80 K(-82.6%) | $123.20 K(+64.9%) | $402.80 K(+0.8%) |
| Sept 2020 | - | $74.70 K(-2.6%) | $399.60 K(-51.6%) |
| June 2020 | - | $76.70 K(-40.2%) | $824.90 K(-52.8%) |
| Mar 2020 | - | $128.20 K(+6.8%) | $1.75 M(-24.6%) |
| Dec 2019 | $2.32 M | $120.00 K(-76.0%) | $2.32 M(+5.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2019 | - | $500.00 K(-50.0%) | $2.20 M(-55.7%) |
| June 2019 | - | $1.00 M(+42.9%) | $4.97 M(+8.8%) |
| Mar 2019 | - | $700.00 K(>+9900.0%) | $4.57 M(+4.6%) |
| Dec 2018 | $4.37 M(+28.5%) | $0.00(-100.0%) | $4.37 M(0.0%) |
| Sept 2018 | - | $3.27 M(+445.0%) | $4.37 M(+74.8%) |
| June 2018 | - | $600.00 K(+20.0%) | $2.50 M(+31.6%) |
| Mar 2018 | - | $500.00 K(>+9900.0%) | $1.90 M(-44.1%) |
| Dec 2017 | $3.40 M(-50.2%) | $0.00(-100.0%) | $3.40 M(-26.1%) |
| Sept 2017 | - | $1.40 M(>+9900.0%) | $4.60 M(+43.8%) |
| June 2017 | - | $0.00(-100.0%) | $3.20 M(0.0%) |
| Mar 2017 | - | $2.00 M(+66.7%) | $3.20 M(-53.2%) |
| Dec 2016 | $6.83 M(+241.7%) | $1.20 M(>+9900.0%) | $6.83 M(+21.3%) |
| Sept 2016 | - | $0.00(0.0%) | $5.63 M(0.0%) |
| June 2016 | - | $0.00(-100.0%) | $5.63 M(-26.2%) |
| Mar 2016 | - | $5.63 M(>+9900.0%) | $7.63 M(+281.7%) |
| Dec 2015 | $2.00 M(-62.9%) | $0.00(0.0%) | $2.00 M(0.0%) |
| Sept 2015 | - | $0.00(-100.0%) | $2.00 M(0.0%) |
| June 2015 | - | $2.00 M(>+9900.0%) | $2.00 M(>+9900.0%) |
| Mar 2015 | - | $0.00 | $0.00 |
| Dec 2014 | $5.39 M | - | - |
FAQ
- What is Bone Biologics annual cash flow from financing activities?
- What is the all time high annual CFF for Bone Biologics?
- What is Bone Biologics annual CFF year-on-year change?
- What is Bone Biologics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Bone Biologics?
- What is Bone Biologics quarterly CFF year-on-year change?
- What is Bone Biologics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Bone Biologics?
- What is Bone Biologics TTM CFF year-on-year change?
What is Bone Biologics annual cash flow from financing activities?
The current annual CFF of BBLG is $5.04 M
What is the all time high annual CFF for Bone Biologics?
Bone Biologics all-time high annual cash flow from financing activities is $7.90 M
What is Bone Biologics annual CFF year-on-year change?
Over the past year, BBLG annual cash flow from financing activities has changed by +$614.30 K (+13.87%)
What is Bone Biologics quarterly cash flow from financing activities?
The current quarterly CFF of BBLG is $1.81 M
What is the all time high quarterly CFF for Bone Biologics?
Bone Biologics all-time high quarterly cash flow from financing activities is $6.86 M
What is Bone Biologics quarterly CFF year-on-year change?
Over the past year, BBLG quarterly cash flow from financing activities has changed by +$1.81 M (+602066.67%)
What is Bone Biologics TTM cash flow from financing activities?
The current TTM CFF of BBLG is $3.90 M
What is the all time high TTM CFF for Bone Biologics?
Bone Biologics all-time high TTM cash flow from financing activities is $8.88 M
What is Bone Biologics TTM CFF year-on-year change?
Over the past year, BBLG TTM cash flow from financing activities has changed by +$1.81 M (+86.16%)